Literature DB >> 6343488

Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis.

G Gazzinelli, N Katz, R S Rocha, D G Colley.   

Abstract

Peripheral blood mononuclear cells (PBMN) from patients with active schistosomiasis mansoni are generally induced to proliferate upon exposure to a soluble worm antigenic preparation (SWAP). In contrast, only 25% of such patients responded to SWAP exposure by the production of detectable levels of a mitogenic factor (MF) activity capable of stimulating proliferation of resting cultures of allogeneic PBMN. When former schistosomal patients (chemotherapeutically cured 10 to 40 yr previously) were tested for these two responses to SWAP, all manifested blastogenesis; 80% also responded by the production of MF activity. Only 9% of control subjects with no history of schistosomiasis produced MF activity when exposed to SWAP. The production and assay of MF activity by former schistosomiasis patients was standardized. Reliable, optimal production was achieved by using 6 X 10(6) PBMN in 2-ml cultures upon exposure to 15 micrograms protein SWAP/ml. The cells were incubated for 20 hr in the presence or absence of SWAP, at which time they were washed and recultured in fresh medium for at least 28 more hours. Subject to subject variability occurred in the optimal time of detection of MF activity in culture supernatant fluids, but detection was assured between 24 and 48 hr after the wash. The assay system for MF detection required a 5 to 7-day culture. The consistent production of MF activity by former schistosomal patients emphasized the longevity of immunologic memory to SWAP, and may indicate a post-treatment decline of immunoregulatory mechanisms that are operative in patients with active schistosome infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343488

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Immune responses during human Schistosomiasis mansoni. Evidence for antiidiotypic T lymphocyte responsiveness.

Authors:  M S Lima; G Gazzinelli; E Nascimento; J C Parra; M A Montesano; D G Colley
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

Authors:  T S L Keesen; L R V Antonelli; D R Faria; L H Guimarães; O Bacellar; E M Carvalho; W O Dutra; K J Gollob
Journal:  Clin Exp Immunol       Date:  2011-07-04       Impact factor: 4.330

3.  Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity.

Authors:  Dayane Andriotti Otta; Fernanda Fortes de Araújo; Vitor Bortolo de Rezende; Elaine Maria Souza-Fagundes; Silvana Maria Elói-Santos; Matheus Fernandes Costa-Silva; Raiany Araújo Santos; Heloísa Alves Costa; Jair Lage Siqueira-Neto; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Effect of praziquantel on certain immune responses of schistosomal Egyptian patients. II. Cell-mediated lymphoproliferative response.

Authors:  A E el-Bassiouny; Z A Shaker; A H el-Kalouby; E H el-Raziky
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

5.  In vitro leishmanicidal, antibacterial and antitumour potential of anhydrocochlioquinone A obtained from the fungus Cochliobolus sp.

Authors:  Fernanda F Campos; Jonas P Ramos; Djalma M DE Oliveira; Tania M A Alves; Elaine M DE Souza-Fagundes; Carlos L Zani; Fabio C Sampaio; Attilio Converti; Betania B Cota
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

6.  Cellular responses and cytokine production in post-treatment hookworm patients from an endemic area in Brazil.

Authors:  S M Geiger; C L Massara; J Bethony; P T Soboslay; R Corrêa-Oliveira
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.

Authors:  Erika W Lamb; Colleen D Walls; John T Pesce; Diana K Riner; Sean K Maynard; Emily T Crow; Thomas A Wynn; Brian C Schaefer; Stephen J Davies
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

8.  Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression.

Authors:  C A S Menezes; M O C Rocha; P E A Souza; A C L Chaves; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives.

Authors:  Marina Azevêdo Souza; Susana Johann; Luciana Alves Rodrigues dos Santos Lima; Fernanda Fraga Campos; Isolda Castro Mendes; Heloisa Beraldo; Elaine Maria de Souza-Fagundes; Patrícia Silva Cisalpino; Carlos Augusto Rosa; Tânia Maria de Almeida Alves; Nívea Pereira de Sá; Carlos Leomar Zani
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

10.  Relationship between intensity of infection and immunomodulation in human schistosomiasis. II. NK cell activity and in vitro lymphocyte proliferation.

Authors:  H Feldmeier; G A Gastl; U Poggensee; C Kortmann; A A Daffalla; H H Peter
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.